East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, has signed a Memorandum of Understanding (MoU) with NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening. This partnership is aimed to support genomic sample analysis in Indonesia's Biomedical and Genome Science Initiative (BGSi). The ceremonial signing of this MoU took place at the East Ventures booth during the Tech in Asia Conference 2023 and was attended by Budi Gunadi Sadikin, Minister of Health of the Republic of Indonesia.
East Ventures announced its first Healthcare fund of US$30 million
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.
Aevice Health secures investment from East Ventures to bring next-generation remote respiratory platform to Southeast Asia
Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum based in Singapore, today announced that it has raised undisclosed funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia.
Genetic testing: Leading the way in preventive care for Southeast Asia
In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in Southeast Asia.
Biotechnology and the future of healthcare in Indonesia
Indonesia generates millions of tonnes of waste daily, making it one of the largest waste-producing countries globally. The country also has the highest municipal waste in Southeast Asia, creating a pressing problem that affects public health, the environment, and the economy. But amidst this crisis lies an opportunity. Entrepreneurs and innovators can create sustainable solutions that can transform waste management practices in Indonesia.
AMILI, a precision gut microbiome firm, raises new funding led by East Ventures
AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.
Riliv transforms mental health access in Indonesia for all
There was no strong reason for Audrey Maximillian Herli to allow bullying to spread, mainly after he saw his friends being bullied for sharing his personal stories and problems on social media.
Promising prospect in achieving equitable access to Indonesia’s healthcare
Even though the digital sector is experiencing waves of 'up and down' amid global challenges such as rising interest rates and difficulties in finding funding, Indonesia's digitalization is still developing rapidly and has the potential to reach a digital golden era.